- Home
- MAX vs PRME Comparison
MAX vs PRME Comparison
Compare MAX & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAX | PRME |
|---|---|---|
| Founded | 2014 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 722.8M | 666.1M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | MAX | PRME |
|---|---|---|
| Price | $7.89 | $3.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $17.00 | $6.42 |
| AVG Volume (30 Days) | 950.9K | ★ 2.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 134.83 | 24.31 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $864,704,000.00 | $2,983,000.00 |
| Revenue This Year | $30.80 | $95.64 |
| Revenue Next Year | $8.49 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 122.78 | N/A |
| 52 Week Low | $7.09 | $1.11 |
| 52 Week High | $13.92 | $6.94 |
Technical Indicators
Market Signals| Indicator | MAX | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 28.41 | 41.05 |
| Support Level | N/A | $3.20 |
| Resistance Level | $11.10 | $4.73 |
| Average True Range (ATR) | 0.54 | 0.24 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 20.00 | 18.86 |
Price Performance
Historical ComparisonAbout MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.